357 filings
6-K
TLSA
Tiziana Life Sciences Ltd
23 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
22 Apr 24
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
10:10am
6-K
TLSA
Tiziana Life Sciences Ltd
19 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
18 Apr 24
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
11 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
gaejj700zm4kcu1nzlzt
5 Mar 24
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
7:00am
6-K
kgcw7x871i3 1zqmf5fc
8 Jan 24
Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients
7:00am
6-K
2ql3jmghk
5 Jan 24
Report of Foreign Private Issuer
9:30am
6-K
egcmvr8c4r
5 Jan 24
Report of Foreign Private Issuer
7:00am
6-K
nnpd9eiqxjd
29 Dec 23
Updated Interim Results for the Six Months Ended 30 June 2023
4:30pm
6-K
yc6xm5q
19 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
phzb12alxrub55mahu
4 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
ikk3 rfqsgz
1 Dec 23
To Be Held As a “Remote Meeting” Only
9:00am
6-K
vev62
30 Nov 23
Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis
7:08am
6-K
5sf9u4rf
1 Nov 23
Report of Foreign Private Issuer
7:00am
6-K
s91un
18 Oct 23
Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment
7:12am
6-K
5oennrfj
16 Oct 23
Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab
7:00am
6-K
yar682odqd98m p7ca1u
13 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
behe1 3wtn
11 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
wquc r3p924ow
26 Sep 23
Report of Foreign Private Issuer
7:00am